We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

223 hedge funds and large institutions have $1.7B invested in Dr. Reddy's Laboratories in 2023 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 81 increasing their positions, 66 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

5,226% more call options, than puts

Call options by funds: $1.86M | Put options by funds: $35K

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

52% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 25

23% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 66

12% more capital invested

Capital invested by funds: $1.51B → $1.7B (+$187M)

7.69% more ownership

Funds ownership: 65.36% → 73.05% (+7.7%)

6% more funds holding

Funds holding: 211 → 223 (+12)

Holders
223
Holders Change
+12
Holders Change %
+5.69%
% of All Funds
3.25%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.07%
New
38
Increased
81
Reduced
66
Closed
25
Calls
$1.86M
Puts
$35K
Net Calls
+$1.83M
Net Calls Change
-$419K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$60.2M
2
Man Group
Man Group
United Kingdom
+$51.2M
3
BlackRock
BlackRock
New York
+$34.6M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$10.6M
5
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$7.79M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$22.9M
2
GQG Partners
GQG Partners
Florida
-$19.1M
3
Ameriprise
Ameriprise
Minnesota
-$15.8M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$14.7M
5
Goldman Sachs
Goldman Sachs
New York
-$9.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
VPIM
76
Vanguard Personalized Indexing Management
California
$1.75M -$96.3K -7,200 -5%
GC
77
Guggenheim Capital
Illinois
$1.69M +$73.4K +5,490 +5%
Nordea Investment Management
78
Nordea Investment Management
Sweden
$1.66M – – –
GT
79
Greenleaf Trust
Michigan
$1.63M -$4.61K -345 -0.3%
RAM
80
Ramirez Asset Management
New York
$1.6M -$141K -10,565 -8%
BNP Paribas Asset Management
81
BNP Paribas Asset Management
France
$1.6M – – –
VA
82
Vident Advisory
Georgia
$1.54M +$198K +14,810 +15%
BCAM
83
Boston Common Asset Management
Massachusetts
$1.49M +$193K +14,450 +16%
S
84
SignatureFD
Georgia
$1.48M +$69K +5,160 +5%
SCM
85
Shelton Capital Management
Colorado
$1.47M +$1.41M +105,410 New
Fidelity Investments
86
Fidelity Investments
Massachusetts
$1.38M +$425K +31,770 +47%
Millennium Management
87
Millennium Management
New York
$1.36M -$22.9M -1,710,245 -95%
Pathstone Holdings
88
Pathstone Holdings
New Jersey
$1.27M +$1.22M +91,160 New
Mariner
89
Mariner
Kansas
$1.25M +$40.5K +3,030 +3%
HJIM
90
Henry James International Management
New York
$1.24M – – –
Victory Capital Management
91
Victory Capital Management
Texas
$1.19M -$91.2K -6,825 -7%
Axa
92
Axa
France
$1.17M – – –
Rockefeller Capital Management
93
Rockefeller Capital Management
New York
$1.16M +$1.11M +83,280 New
LAM
94
Lifestyle Asset Management
Texas
$1.06M -$43.7K -3,270 -4%
UBS Group
95
UBS Group
Switzerland
$1.04M -$59.9K -4,480 -6%
PCM
96
Prelude Capital Management
New York
$1.04M – – –
QI
97
Qtron Investments
Massachusetts
$1.02M +$247K +18,450 +34%
BCI
98
Brinker Capital Investments
Pennsylvania
$1.02M +$458K +34,230 +89%
OPS
99
Orion Portfolio Solutions
Nebraska
$1.02M +$458K +34,230 +89%
CS
100
Credit Suisse
Switzerland
$1.01M -$73.3K -5,480 -7%
2 3
4
5 6

RDY Hedge Fund Activity: Q4 2023 in Review

223 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2023, worth a combined $1.7B — up 12% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new RDY positions and 25 closed out — a net gain of 13 holders — while 81 added to existing stakes and 66 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $60.2M. The largest seller was Millennium Management, cutting an estimated $22.9M.

  • 223 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2023, up from 211 in Q3 2023.
  • Funds reported $1.7B of Dr. Reddy's Laboratories stock for Q4 2023, up 12% quarter-over-quarter.
  • 38 funds opened new Dr. Reddy's Laboratories positions in Q4 2023 and 25 closed out, a net change of +13 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q4 2023 was Morgan Stanley, an estimated $60.2M added.
  • The largest Dr. Reddy's Laboratories seller in Q4 2023 was Millennium Management, an estimated $22.9M sold.

Based on aggregated 13F filings for Q4 2023.